Albany, NY -- (SBWIRE) -- 02/19/2016 -- 'Platelet Aggregation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023,' a new report by Transparency Market Research, offers actionable insight into the market's dynamics. Platelet aggregation is a condition that occurs in the chain of events leading up to the formation of a blood clot. Platelet aggregation can be studied through specific tests. This test is commonly conducted before a surgery, to diagnose any dysfunction in the platelet, and so on.

The growing incidence of diseases such as dengue and malaria in Asia and a higher number of people undergoing surgeries across the world will likely fuel the global platelet aggregation devices market till 2023.

To conduct a meticulous study of the global platelet aggregation devices market, the report segments the market based on device type, end users, and geography.

Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6541

By device type, the market has been segmented into: platelet function analyzer (PFA), platelet function centrifuge, aggregometers, consumables and accessories, and platelet collection systems. Of these, PFA has been identified as the most widely used platelet aggregation device given its critical task of aspirating in-virto blood collected as a sample into the cartridge test. The PFA helps diagnosticians study platelet function and count besides other specific elements.

Furthermore, studying the market on the basis of end users, the report segments the global platelet aggregation devices market into diagnostic laboratories, hospitals, CROs and medical research institutes, and other end users.

To study the most attractive regional markets, the report divides the global platelet aggregation devices market into the following geographical segments: North America (U.S and Canada), Europe, Asia Pacific, and Rest of the World. The United States and Canada dominate the global platelet aggregation devices market and are trailed by Europe in the second position globally. The leading position of these regions can be ascribed to the presence of leading players seated in the developed countries in North America and Europe.

The opportunities, however, are gradually moving eastward with the remarkable growth of countries in the Asia Pacific region. Mosquito-borne diseases such as malaria and dengue are on the rise in countries such as India, where the demand for platelet aggregation devices will continue to show an uptick.

Worldwide, the demand for platelet rich aggregation devices doesn't just stem from screening programs for epidemics such as dengue and HIV. The market can also expect to see new opportunities among patients undergoing anti-platelet therapy.

The ability to present a clear result with the use of a minimal blood sample is a feature users look for in platelet aggregation devices. However, purchase decisions could be restrained by the high cost and limited usage of such devices. Companies that rake in an appreciable portion of revenue in the global platelet rich aggregation devices market are: Bio Data Corporation, Haemonetics Corporation, Drucker Diagnostics, F. Hoffmann-La Roche Ltd., Helena Laboratories, Siemens Healthcare, Laboratory Corporation of America Holdings (LabCorp), and Sienco.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/